1 Min Read
April 5 (Reuters) - Loxo Oncology Inc:
* Loxo Oncology announces acceptance of larotrectinib oral presentations at the American Society Of Clinical Oncology (asco) annual meeting Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.